Detalhe da pesquisa
1.
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer.
Stem Cells
; 42(6): 526-539, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563224
2.
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
Oncologist
; 28(4): 364-e217, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640137
3.
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
BJU Int
; 127(4): 435-444, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969563
4.
A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer.
Oncologist
; 25(12): 1013-e1824, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510664
5.
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 118(4): 590-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780387
6.
Metabolic syndrome in prostate cancer: impact on risk and outcomes.
Future Oncol
; 12(16): 1947-55, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067408
7.
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.
BJU Int
; 116(4): 546-55, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407442
8.
Beyond PSA: managing modern therapeutic options in metastatic castration-resistant prostate cancer.
South Med J
; 108(4): 224-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25871992
9.
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Eur Urol Oncol
; 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858437
10.
Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.
Oncologist
; 17(3): 312-20, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382457
11.
The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer.
Urol Clin North Am
; 47(4): 457-467, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33008496
12.
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
Clin Cancer Res
; 24(17): 4332-4345, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748182
13.
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.
Clin Genitourin Cancer
; 15(1): 77-85, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27328856
14.
Angiogenesis inhibitors in the treatment of prostate cancer.
Chem Immunol Allergy
; 99: 197-215, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24217611